drugset / Trial / NCT03114085
Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
It is an open,randomized,controlled study, and the purpose of this study is to observe and evaluate the efficacy and safety of Apatinib combined with Capecitabine in the treatment of patients with advanced hepatocellular carcinoma.
Timeline
- Start
- 2017-05-20
- Primary completion
- 2019-03-20
- Completion
- 2019-05-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 1000 mg/m2 | Oral |
| Subject | Rivoceranib | Small molecule | 500 mg | Oral |